From Despair to Rebirth: A Three-Year Survivor's Testimony of Living with Advanced Lung Cancer

From Despair to Rebirth: A Three-Year Survivor's Testimony of Living with Advanced Lung Cancer

When I was diagnosed at a provincial hospital in March 2023 with poorly differentiated adenocarcinoma of the left upper lung and spinal metastases to the thoracic and lumbar vertebrae due to lower back pain accompanied by numbness in both legs, when words like "advanced lung cancer" and "risk of high paraplegia" sliced through the tranquility of my life like sharp blades, I once believed this was the final chapter of my life.

1 A glimmer in the darkness

On the day of diagnosis, I curled up in the hospital corridor, counting the cracks in the floor tiles as if measuring the days left in my life. When the chemotherapy needle pierced my vein, I told myself, "This might be the last time I feel pain." But the tears of my family and the encouragement of my friends were like fireflies in the dark night—faint, yet bright enough to illuminate the path ahead.

2 Days of Racing Against Death

Accompanied by my family, I made my way to the Chemotherapy Department of Wuwei Cancer Hospital. With the precise treatment and support from Director Wang Huijuan and her medical team, a multidisciplinary approach was first adopted: I underwent "posterior lumbar 1 vertebral canal decompression and fusion, nerve release and internal fixation + L5 vertebral body cementoplasty." This was followed by 6 cycles of regular "immunotherapy combined with palliative chemotherapy," along with zoledronic acid bone protection treatment every 28 days. Subsequently, I received stereotactic body radiotherapy (SBRT) for the thoracic and lumbar vertebral metastases. Afterward, my condition stabilized following 2 years of regular immunotherapy maintenance, and treatment was discontinued. To date, three full years have passed, and my condition remains stable. When the treatment ended, I suddenly realized: living itself is the most precious gift of all.

3 Looking back at the self who survived the disaster, it turns out that everything has cracks, and that's where the light shines through

Grateful that time has not forsaken me, bestowing upon me a journey strewn with thorns; thankful for the years' kindness, granting me a life of wandering. For the rest of my days, I shall eventually become immune to all harm, my smile unrestrained. Now, looking back from the shore of time, those days and nights battling the disease have long been forged into medals of honor gifted by life.

When the chemotherapy needle pierced my vein, even my breath tasted of rust; during those sleepless nights tossing and turning, the moonlight outside the window was as cold as a verdict. But standing here now, touching the words "no abnormalities detected" on my follow-up report, I suddenly realize: at the very end of the darkest tunnel, light truly does hide.

Three years ago, I thought cancer was the end of life; now I understand, it was the starting point of my rebirth. Those days of being ground down taught me: true bravery isn't about never falling, but being able to hum a tune and get back up after you fall.

You see, spring has arrived again.

Today, I deliberately wore a red dress when I went out, just like when I first walked out of the hospital three years ago. Cherry blossoms are falling rustling in the wind, children run by flying kites, and the old man selling candied hawthorns smiles, his face full of wrinkles. I suddenly remember the words I wrote during treatment: "If living is a game, then defeating cancer is an achievement I can brag about for a lifetime, right?"

Yes, I won. And this victory is called "being alive."

4 Thanks to the medical and nursing team of the Chemotherapy Department at Wuwei Cancer Hospital in Gansu Province. With your exquisite medical skills, precise anti-cancer strategies, warm help and care, you have brought me from the abyss of despair to a path filled with sunshine. Thank you for paving the way of rebirth for me with love

The Chemotherapy Department of Gansu Wuwei Cancer Hospital was established in February 2009. It currently has a medical team consisting of 1 Chief Physician, 2 Associate Chief Physicians, 3 Attending Physicians, and 1 Resident Physician. The department treats over 1,200 cancer patients annually with chemotherapy, making it the oncology department with the largest treatment volume and the most standardized treatment protocols in the Wuwei region.

Department Director

Wang Huijuan, Chief Physician, has been engaged in oncology work for over twenty years. She specializes in the diagnosis, chemotherapy, molecular targeted therapy, immunotherapy, and endocrine therapy for lung cancer, gastric cancer, esophageal cancer, colorectal cancer, pancreatic cancer, biliary tract tumors, gynecological tumors, breast cancer, lymphoma, and malignant solid tumors of the urinary system, as well as the diagnosis and treatment of complex oncological cases. She was awarded the title of "Gansu Province Excellent Physician" in 2020.

Her academic positions include:

- Deputy Chairman of the Primary Tumor Multidisciplinary Collaboration Professional Group, Tumor Physicians Branch, Gansu Medical Doctors Association

- Standing Committee Member of the First Committee, Tumor Drug Clinical Research Professional Committee, Gansu Anti-Cancer Association

- Standing Committee Member of the First Committee, Cancer Pain Treatment Professional Committee, Gansu Anti-Cancer Association

- Deputy Chairman of the Second Tumor Professional Committee, Wuwei City Medical Association

- Director of the Wuwei Branch Center, Gansu Provincial Clinical Medical Research Center for Thoracic Tumors - Gansu Wuwei Cancer Hospital

Clinical Services and Capabilities

The department provides a comprehensive range of services for various solid tumors, including:

- Diagnosis, neoadjuvant chemotherapy, and postoperative adjuvant chemotherapy

- Chemotherapy for intermediate and advanced-stage tumors, and comprehensive treatment for advanced metastatic tumors

- Biological immunotherapy such as CIK and NK cell therapies

- Endocrine therapy

- Local drug injection therapy

- Collaboration with the Pathology Department for genetic testing, pioneering molecular targeted therapy and immune checkpoint inhibitor therapy in Wuwei City

- Cooperation with the Pharmacy Department for therapeutic drug monitoring to enhance treatment efficacy and ensure safe, effective, and rational medication use

Through the establishment of a "Demonstration Ward for Standardized Cancer Pain Treatment," the department achieves a pain-free state for cancer patients within 24 hours of admission, significantly improving their quality of life and enhancing adherence to anti-tumor therapy, thereby maximizing patient benefits. The creation of a "Chemotherapy-Induced Nausea and Vomiting (CINV) Free Ward" has improved the standardized management concepts of CINV among medical staff, enabling the formulation of individualized antiemetic regimens to minimize the adverse effects of chemotherapeutic drugs.

The department routinely performs procedures such as bone marrow aspiration, bone marrow biopsy, lumbar puncture + intrathecal injection, thoracentesis and paracentesis, and pericardiocentesis. It has led and participated in numerous drug clinical trials, all of which have been completed successfully, bringing hope and benefits to a large number of patients.

- March 2013: Designated as one of the first "Demonstration Wards for Standardized Cancer Pain Treatment" by the Gansu Provincial Health Department.

- August 2015: Hosted the "Municipal Training Course on Narcotics Management and Standardized Cancer Pain Treatment" organized by the Wuwei Municipal Health Commission, providing training to clinicians from medical institutions in Wuwei City, Liangzhou District, and Minqin County to promote standardized cancer pain treatment and rational clinical drug use.

- 2017: Won the First Prize (Team Award) in the "Provincial Standardized Cancer Pain Treatment Skills Competition" organized by the Gansu Provincial Health Department, competing against 34 hospitals.

- August 2018: Became a "Member Unit of the Close-knit Specialty Alliance for Comprehensive Cancer Treatment" with the First Hospital of Lanzhou University.

- October 2019: Became a "Member Unit of the Gansu Provincial Lung Cancer Prevention and Treatment Alliance" and won the Third Prize in the "2019 Gansu Provincial Lung Cancer MDT Competition."

- May 2021: Recognized as a "Municipal Key Clinical Discipline" by the Wuwei Municipal Health Commission.

- July 2022: Became a "Branch Center of the Gansu Provincial Clinical Medical Research Center for Thoracic Tumors."

- September 2022: Won the Second Prize in the "Second Chinese Colorectal Cancer MDT Competition (Gansu Division)."

- August 2023: Recognized as a "Municipal Excellent Physician Team" by the Wuwei Municipal Health Commission.

- February 2024: Accredited as a "Provincial Key Clinical Discipline (Class B)" by the Gansu Provincial Health Commission.

- June 2024: Designated as a "National Demonstration Ward for Standardized CINV Management" by the Committee of Cancer Rehabilitation and Palliative Care, China Anti-Cancer Association.

- November 2025: Won the Second Prize in the "Provincial Standardized Cancer Pain Treatment Skills Competition" organized by the Gansu Provincial Health Commission.

- April 2010 & May 2023: Recognized as an "Excellent Nursing Team" by the Wuwei Cancer Hospital.